Some research has reported that tumors like esophageal carcinoma (40), colon carcinoma (41), bladder carcinoma (42), breast cancer (31), prostate carcinoma (31), and non-small cell carcinoma (27) presented a lower expression of DMBT1 compared with normal tissues. This evidence concerns the gene DMBT1 and urinary bladder carcinoma.